Macrophage dysregulation in inflammatory bowel disease: cellular heterogeneity, pathogenic mechanism, and treatment - Top-Institutions - MDSpire

Macrophage dysregulation in inflammatory bowel disease: cellular heterogeneity, pathogenic mechanism, and treatment

  • By

  • Yuanyuan Yang

  • Haiying Zhu

  • May 21, 2026

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Gastroenterology

  • #2

    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai

    New York, New York

    Key Differentiators

    • Gastroenterology

  • #3

    Shiga University of Medical Science
    Shiga University of Medical Science

    Otsu, Shiga

    Key Differentiators

    • Gastroenterology

  • #4

    Sheba Medical Center
    Sheba Medical Center

    Tel HaShomer, Israel

    Key Differentiators

    • Gastroenterology

  • #5

    Cincinnati Children's Hospital Medical Center
    Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio

    Key Differentiators

    • Pediatric Gastroenterology

Original Source(s)

Macrophage dysregulation in inflammatory bowel disease: cellular heterogeneity, pathogenic mechanism, and treatment

  • by Yuanyuan Yang, Haiying Zhu

  • May 21, 2026

Related Content

Risk of intestinal involvement in mucocutaneous-onset Behçet’s disease: data from the AIDA network registry

Therapeutic Approaches for Inflammatory Bowel Disease: The Role of Immunomodulators, Biologics, and 5-Aminosalicylates in Cardiovascular Risk Management

Genes Predict Bowel Disease Severity

Large study suggests genetic risk scores could help doctors identify patients who need closer monitoring and earlier treatment

  • March 12, 2026

  • 2 min